Anti-interleukin-5 therapy and severe asthma.
Szczeklik
Andrew
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000145:classification / Q000188:drug therapy* / Q000209:etiology; D004802:Eosinophilia / Q000188:drug therapy*; D006801:Humans; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D010641:Phenotype; D012008:Recurrence
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5; C434107:mepolizumab; D001241:Aspirin